March 28, 2023
PAR-20-215 Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
PAR-20-216 NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
PAR-20-217 NCCIH Natural Product Phase Early Phase Clinical Trial Award (R33 Clinical Trial Required)
PAR-20-218 NCCIH Natural Product Phase Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
PAR-20-219 Natural Product, Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
National Center for Complementary and Integrative Health (NCCIH)
The purpose of this Notice of Change to Funding Opportunity is to extend by one application cycle NCCIH's natural product clinical trial notices of funding opportunities: PAR-20-218, PAR-20-217, PAR-20-216, PAR-20-215, and PAR-20-219.
An additional receipt date has been added, June 5, 2023 (New), June 15, 2023 (Resubmissions, Renewals and Revisions) and September 7, 2023 (AIDS and AIDS-related); these NOFOs now expire on September 8, 2023.
The NOFO currently reads as:
Part 1. Overview Information, Key Dates
Application Due Date(s)
New Applications: July 20, 2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023
Resubmission and Revision: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this notice of funding opportunity are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s):
September 07, 2020; May 07, 2021; January 07, 2022; September 07, 2022; May 07, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this notice of funding opportunity are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review: November 2020, July 2021, March 2022, November 2022, July 2023
Advisory Council Review: January 2021, October 2021, May 2022, January 2023, October 2023
Earliest Start Date: April 2021, December 2021, July 2022, April 2023, December 2023
Expiration Date: May 8, 2023
The NOFO has been modified as follows: (changes in italics)
Application Due Date(s)
New Applications: July 20, 2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023; June 05, 2023
Resubmission and Revision: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023; June 15, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this notice of funding oportunity are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s):
September 07, 2020; May 07, 2021; January 07, 2022; September 07, 2022; May 07, 2023; September 07, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this notice of funding opportunity are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review: November 2020, July 2021, March 2022, November 2022, July 2023, November 2023
Advisory Council Review: January 2021, October 2021, May 2022, January 2023, October 2023, January 2024
Earliest Start Date: April 2021, December 2021, July 2022, April 2023, December 2023, April 2024
Expiration Date: September 8, 2023
All other aspects of these NOFOs remain the same.
Wendy Weber, ND, PhD, MPH
Nationa l Center for Complementary and Integrative Health (NCCIH)
Phone: 301-402-1272
Email: wendy.weber@nih.gov
and Human Services (HHS)
